Data / Form D filings / Sentrimed, Inc.
Sentrimed, Inc.: Form D filings
Sentrimed, Inc., a biotechnology company in Mullica Hill, NJ, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on May 13, 2026, reports $250,000 sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 107 GILBRETH PARKWAY, Mullica Hill, NJ, 08062
- Phone
- (856) 651-7140
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2014313
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2026 | New notice | $1,000,000 | $250,000 | $750,000 | 1 | May 8, 2026 | sec.gov |
| Mar 7, 2024 | New notice | $1,500,000 | $500,000 | $1,000,000 | 1 | Feb 28, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Ragatz | Executive Officer, Director | |
| Bradley Galer | Director | |
| Jack Goldberg | Executive Officer, Director | |
| Mari Rhodehamel Yin | Executive Officer, Director | |
| Gary Goldberg | Executive Officer | |
| Arye Rosen | Executive Officer | |
| Christopher Leonard | Executive Officer | |
| Tabbetha Dobbins | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of May 11, 2026 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sentrimed, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.